Company news
Impedimed Limited (ASX:IPD) news
Impedimed Limited news releases on 6ix. Latest, Jul 27, 2026: Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
Press releases & updates
Quarterly Activities Report and Appendix 4C - Jun-2026 Qtr
July 27, 2026
Oversubscribed Share Purchase Plan Successfully Completed
June 9, 2026
CEO Business Update
June 1, 2026
Equity Raising Investor Presentation
May 4, 2026
ImpediMed announces a successful $15.2 million Capital Raise
May 3, 2026
Quarterly Activities Report and Appendix 4C - Mar-2026 Qtr
April 29, 2026
ImpediMed Appoints Erik Anderson as Chief Executive Officer
April 7, 2026
Appointment of CEO/Managing Director
April 6, 2026
FY26 Half Year Financial Results
February 25, 2026
Appendix 4D and Interim Financial Report
February 25, 2026
ImpediMed Appoints Medical Technology Commercialization Expert Erik Anderson to Board of Directors
February 25, 2026
Quarterly Activities Report and Appendix 4C - Dec-2025
January 28, 2026
Quarterly Activities Report and Appendix 4C - Sep-2025 Qtr
October 29, 2025
Major US health insurer publishes positive coverage
October 1, 2025
Appendix 4E
August 27, 2025
Quarterly Activities Report and Appendix 4C - Jun-2025 Qtr
July 30, 2025
Q4 FY25 sales and growth capital facility update
July 16, 2025
Quarterly Activities Report and Appendix 4C - Mar-2025 Qtr
April 29, 2025
S&P DJI Announces March 2025 Quarterly Rebalance
March 7, 2025
ImpediMed secures US$15 million growth capital facility
February 5, 2025
Quarterly Activities Report and Appendix 4C - Dec-2024 Qtr
January 30, 2025
Presentation - Bell Potter Conference
November 17, 2024
Quarterly Activities Report and Appendix 4C - Sep-2024 Qtr
October 21, 2024
Investor Presentation
October 21, 2024
Positive coverage published by two additional payors
September 23, 2024
HealthInvest Presentation
September 18, 2024
FY2024 Results
August 28, 2024
Quarterly Activities Report and Appendix 4C - Jun-2024 Qtr
July 28, 2024
Appointment of CEO and CF&OO
July 22, 2024
Quarterly Activities Report and Appendix 4C - March-2024 Qtr
April 29, 2024
Organisational Changes
April 16, 2024
S&P DJI Announces March 2024 Quarterly Rebalance
March 1, 2024
ImpediMed 2024 Half-Year Financial Results
February 26, 2024
Quarterly Activities Report and Appendix 4C - Dec-23 Qtr
January 31, 2024
ImpediMed announces leadership and Board changes
November 19, 2023
Largest US Private Payor Updates Medical Policy for BIS
November 2, 2023
Appendix 4C & Quarterly Activities Report - Sep-23 Qtr
October 30, 2023
APPENDIX 4C - Quarterly Activities Report
July 23, 2023
First Top 5 National Payor Covering SOZO Testing
July 19, 2023
ImpediMed Achieves Critical Mass in First Key Target State
June 28, 2023
SPP Results
June 21, 2023
ImpediMed Announces Third Medical Policy Covering SOZO
June 20, 2023
First Published Medical Policy from Blue Cross Blue Shield
June 4, 2023
Share Purchase Plan Opens
May 30, 2023
First Published Medical Policy for Bioimedance Spectroscopy
May 24, 2023
Capital Raising Investor Presentation
May 18, 2023
Placement and SPP Notification
May 18, 2023
Trading Halt
May 17, 2023
SOZO Pro Achieves Clearance by U.S. FDA
May 4, 2023
Appendix 4C & Quarterly Activities Report - Mar-23 Qtr
April 16, 2023